These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 206056

  • 1. [Inhibition of metabolism of triglyceride-rich lipoproteins by postheparin lipolytic activity in hyperlipoproteinemia type III].
    Augustin J, Geursen R, Wieland H, Klose G, Greten H.
    Verh Dtsch Ges Inn Med; ; 83():387-9. PubMed ID: 206056
    [No Abstract] [Full Text] [Related]

  • 2. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.
    Brunzell JD, Hazzard WR, Porte D, Bierman EL.
    J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459
    [Abstract] [Full Text] [Related]

  • 3. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C, Tremblay M, Fredenrich A, Davignon J, Cohn JS.
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [Abstract] [Full Text] [Related]

  • 4. Bile acid metabolism in hyperlipoproteinaemia.
    Hellström K, Einarsson K.
    Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796
    [No Abstract] [Full Text] [Related]

  • 5. Lipoprotein binding and hypertriglyceridemia in chronic uremia.
    Samar RE, Moncrief JW, Decherd JF, Popovich RP.
    Trans Am Soc Artif Intern Organs; 1975 Jan; 21():455-63. PubMed ID: 167492
    [No Abstract] [Full Text] [Related]

  • 6. [Relationship between the activity of lecithin cholesterol acyltransferase, hyperlipoproteinemia type and the indicators of the system of hemostasis in chronic ischemic heart disease].
    Furkalo NK, Bol'shakova RM, Solovtsova KM, Mkhitarian LS, Progonnaia VV.
    Vrach Delo; 1978 Dec; (12):33-8. PubMed ID: 217177
    [No Abstract] [Full Text] [Related]

  • 7. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
    Hazzard WR, Bierman EL.
    Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
    [Abstract] [Full Text] [Related]

  • 8. Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia.
    Krauss RM, Levy RI, Fredrickson DS.
    J Clin Invest; 1974 Nov; 54(5):1107-24. PubMed ID: 4370795
    [Abstract] [Full Text] [Related]

  • 9. Studies on serum lipoproteins of rats developing spontaneous hyperlipidemia.
    Gustafsson K, Kiessling H.
    Artery; 1981 Nov; 9(6):456-76. PubMed ID: 7337554
    [Abstract] [Full Text] [Related]

  • 10. Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases.
    Huttunen JK, Pasternack A, Vänttinen T, Ehnholm C, Nikkilä EA.
    Acta Med Scand; 1978 Nov; 204(3):211-8. PubMed ID: 211802
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical aspects of hyperlipoproteinemia.
    Crepaldi G, Fellin R.
    Ann Biol Clin (Paris); 1974 Nov; 32(4):309-22. PubMed ID: 4376343
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
    Weisweiler P, Schwandt P.
    Verh Dtsch Ges Inn Med; 1974 Nov; 83():398-401. PubMed ID: 206058
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.